Synergistic protective effect of paeoniflorin and β-ecdysterone against rotenone-induced neurotoxicity in PC12 cells

Apoptosis

Volumn 21, Issue 12, 2016, Pages 1354-1365

  Liu, Han ^a   Yu, Chunlei ^a   Xu, Tianjiao ^a   Zhang, Xiaojie ^a   Dong, Miaoxian ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Paeoniflorin; Parkinson s disease; Synergism; Ecdysterone

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CASPASE 3; CASPASE 9; ECDYSTERONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PAEONIFLORIN; PROTEIN BAX; PROTEIN KINASE C DELTA; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; ROTENONE; ROTTLERIN; TRANSCRIPTION FACTOR NRF2; GLUCOSIDE; NEUROPROTECTIVE AGENT; TERPENE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VIVO STUDY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CYTOLOGY; DRUG EFFECTS; NERVE CELL;

ANIMALS; APOPTOSIS; DRUG SYNERGISM; ECDYSTERONE; GLUCOSIDES; MONOTERPENES; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; RATS; ROTENONE;

EID: 84989195518     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-016-1293-7     Document Type: Article

References (45)

1. Tahmasian M, Bettray LM, van Eimeren T, Drzezga A, Timmermann L, Eickhoff CR, Eickhoff SB, Eggers C (2015) A systematic review on the applications of resting-state fMRI in Parkinson’s disease: does dopamine replacement therapy play a role? Cortex 73:80–105
2. Xu Y, Deng Y, Qing H (2015) The phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson’s disease. J Neurochem 135:4–18
3. Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ, Rozemuller AJ, van de Berg WD; Netherlands Brain Bank (2014) Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson’s disease. Mov Disord 29:1244–1251
4. Berndt N, Holzhütter HG, Bulik S (2013) Implications of enzyme deficiencies on mitochondrial energy metabolism and reactive oxygen species formation of neurons involved in rotenone-induced Parkinson’s disease: a model-based analysis. FEBS J 280:5080–5093
5. Zhou Q, Liu C, Liu W, Zhang H, Zhang R, Liu J, Zhang J, Xu C, Liu L, Huang S, Chen L (2015) Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis. Toxicol Sci 143:81–96
6. Hu XL, Niu YX, Zhang Q, Tian X, Gao LY, Guo LP, Meng WH, Zhao QC (2015) Neuroprotective effects of Kukoamine B against hydrogen peroxide-induced apoptosis and potential mechanisms in SH-SY5Y cells. Environ Toxicol Pharmacol 40:230–240
7. Kasote DM, Katyare SS, Hegde MV, Bae H (2015) Significance of antioxidant potential of plants and its relevance to therapeutic applications. Int J Biol Sci 11:982–991
8. Fu W, Zhuang W, Zhou S, Wang X (2015) Plant-derived neuroprotective agents in Parkinson’s disease. Am J Transl Res 7:1189–1202
9. Kumar H, Kim IS, More SV, Kim BW, Choi DK (2014) Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat Prod Rep 31:109–139
10. Yang C, Zhao J, Cheng Y, Le XC, Rong J (2015) N-Propargyl caffeate amide (paca) potentiates nerve growth factor (NGF)-induced neurite outgrowth and attenuates 6-hydroxydopamine (6-OHDA)-induced toxicity by activating the Nrf2/HO-1 pathway. ACS Chem Neurosci 6:1560–1569
11. Xia B, Liu H, Xie J, Wu R, Li Y (2015) Akt enhances nerve growth factor-induced axon growth via activating the Nrf2/ARE pathway. Int J Mol Med 36:1426–1432
12. Zou Y, Wang R, Guo H, Dong M (2015) Phytoestrogen β-ecdysterone protects PC12 cells against MPP+-induced neurotoxicity in vitro: involvement of PI3K-Nrf2-regulated pathway. Toxicol Sci 147:28–38
13. Pranski E, Van Sanford CD, Dalal N, Orr AL, Karmali D, Cooper DS, Gearing M, Lah JJ, Levey AI, Betarbet R (2013) NF-κB activity is inversely correlated to RNF11 expression in Parkinson’s disease. Neurosci Lett 547:16–20
14. Pišlar AH, Zidar N, Kikelj D, Kos J (2014) Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells. Neuropharmacology 82:121–131
15. Dong H, Li R, Yu C, Xu T, Zhang X, Dong M (2015) Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway. Neuroscience 285:70–80
16. Zhao YF, Zhang Q, Xi JY, Li YH, Ma CG, Xiao BG (2015) Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson’s disease. J Neurol Sci 353:28–37
17. Xie L, Ge X, Tan H, Xie L, Zhang Y, Hart T, Yang X, Bourne PE (2014) Towards structural systems pharmacology to study complex diseases and personalized medicine. PLoS Comput Biol 10:e1003554
18. Liu LF, Song JX, Lu JH, Huang YY, Zeng Y, Chen LL, Durairajan SS, Han QB, Li M (2015) Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson’s disease. Sci Rep 5:16862
19. Zhu Y, Zhang Z, Zhang M, Mais DE, Wang MW (2010) High-throughput screening for bioactive components from traditional Chinese medicine. Comb Chem High Throughput Screen 13:837–848
20. Arocho A, Chen B, Ladanyi M, Pan Q (2006) Validation of the 2−∆∆Ct calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol 15:56–61
21. Westphal D, Kluck RM, Dewson G (2014) Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ 21:196–205
22. Scorrano L (2009) Opening the doors to cytochrome c: changes in mitochondrial shape and apoptosis. Int J Biochem Cell Biol 41:1875–1883
23. Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson’s disease. Front Neuroanat 9:91
24. Lv E, Deng J, Yu Y, Wang Y, Gong X, Jia J, Wang X (2015) Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson’s disease. Free Radic Res 49:1296–1307
25. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci USA 94:7531–7536
26. Liu J, Yang D, Minemoto Y, Leitges M, Rosner MR, Lin A (2006) NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta. Mol Cell 21:467–480
27. Stocchi F (2014) Therapy for Parkinson’s disease: what is in the pipeline? Neurother 11:24–33
28. Wang Y, Fan X, Qu H, Gao X, Cheng Y (2012) Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Curr Top Med Chem 12:1356–1362
29. 2-induced apoptosis in PC12 cells by modulation of reactive oxygen species and the inflammatory response. Exp Ther Med 9:1768–1772
30. Salminen LE, Paul RH (2014) Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review. Rev Neurosci 25:805–819
31. Kouti L, Noroozian M, Akhondzadeh S, Abdollahi M, Javadi MR, Faramarzi MA, Mousavi S, Ghaeli P (2013) Nitric oxide and peroxynitrite serum levels in Parkinson’s disease: correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci 17:964–970
32. Tsai KL, Cheng YY, Leu HB, Lee YY, Chen TJ, Liu DH, Kao CL (2015) Investigating the role of Sirt1-modulated oxidative stress in relation to benign paroxysmal positional vertigo and Parkinson’s disease. Neurobiol Aging 36:2607–2616
33. McManus MJ, Murphy MP, Franklin JL (2014) Mitochondria-derived reactive oxygen species mediate caspase-dependent and -independent neuronal deaths. Mol Cell Neurosci 63:13–23
34. Perfeito R, Lázaro DF, Outeiro TF, Rego AC (2014) Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells. Mol Cell Neurosci 62:51–59
35. Yen CC, Ho TJ, Wu CC, Chang CF, Su CC, Chen YW, Jinn TR, Lu TH, Cheng PW, Su YC, Liu SH, Huang CF (2011) Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Arch Toxicol 85:565–575
36. Ye S, Chen M, Jiang Y, Chen M, Zhou T, Wang, Y, Hou Z, Ren L (2014) Polyhydroxylated fullerene attenuates oxidative stress-induced apoptosis via a fortifying Nrf2-regulated cellular antioxidant defence system. Int J Nanomedicine 9:2073–2087
37. Tsou YH, Shih CT, Ching CH, Huang JY, Jen CJ, Yu L, Kuo YM, Wu FS, Chuang JI (2015) Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity. Exp Neurol 263:50–62
38. Dewson G (2015) Investigating Bax subcellular localization and membrane integration. Cold Spring Harb Protoc 467–471
39. Harischandra DS, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2015) α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease. Toxicol Sci 143:454–468
40. Kavitha M, Nataraj J, Essa MM, Memon MA, Manivasagam T (2013) Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson’s disease mice. Chem Biol Interact 206:239–247
41. Nitti M, Furfaro AL, Traverso N, Odetti P, Storace D, Cottalasso D, Pronzato MA, Marinari UM, Domenicotti C (2007) PKC delta and NADPH oxidase in AGE-induced neuronal death. Neurosci Lett 416:261–265
42. Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG (2005) Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death. Brain Res Mol Brain Res 139:137–152
43. Yang Y, Kaul S, Zhang D, Anantharam V, Kanthasamy AG (2004) Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration. Mol Cell Neurosci 25:406–421
44. Satoh A, Gukovskaya AS, Nieto JM, Cheng J.H, Gukovsky I, Reeve JR. Jr, Shimosegawa T, Pandol SJ (2004) PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 287:G582–G591
45. Voshavar C, Shah M, Xu L, Dutta AK (2015) Assessment of protective role of multifunctional dopamine agonist D-512 against oxidative stress produced by depletion of glutathione in PC12 cells: implication in neuroprotective therapy for Parkinson’s disease. Neurotox Res 28:302–318